Browse by category

Research presented at the 2026 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) has found that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be associated with improved short-term postoperative benefits, alongside possible long-term risks of osteoporosis, gout and osteomalacia compared with non-users. “We are just now reaching the precipice where five- and 10-year follow-up data are becoming available for patients taking GLP-1 medications,” sa